THE SHORT ANSWER
Reconcile supported annual pharmacy collections, product costs, actual payer adjustments and necessary continuing work before selecting relevant sold comparisons. Prescription counts and billed claims are separate from collected earnings. Historical retail-pharmacy owner-earnings observations do not establish specialty/platform EBITDA or dollars per script. Define stock, receivables and actual payer/operating rights in the proposed price.
Use reported sold retail-pharmacy context
BizBuySell reports pharmacy sale-price multiples relative to owner earnings for 2021–2025; the category is primarily local retail.
(BizBuySell: pharmacy sold benchmarks)| Reported sold pharmacy owner-earnings statistic, 2021–2025 | Multiple |
|---|---|
| Lower quartile | 1.69x |
| Median | 2.45x |
| Mean | 2.79x |
| Upper quartile | 3.75x |
Obtain relevant closed pharmacies with matching geography, scale, actual services/products, earnings definitions, owner duties and asset scope. Record source/date, sold versus asking and unknown fields. Do not select a multiple from script count, age, a manager or a buyer label alone. Distinguish owner-operator SDE from earnings after necessary pharmacist/management coverage.
Bridge actual dispensing receipts to supported annual earnings
Trace completed dispensing through claims, reversals/resubmissions, patient payments, payer remittances, contract adjustments, refunds and receipts on consistent periods. Review open claims, recoupment questions, supplier credits and payment timing with appropriate pharmacy billing/accounting professionals. Define fees/rebates and cost basis consistently; do not deduct an adjustment twice when it is already reflected in receipts or acquisition cost.
| Invented completed-dispensing cohort illustration | Assumption/result |
|---|---|
| Assumed payer receipts before the distinct adjustment below | $100,000 |
| Distinct patient receipts | $10,000 |
| Distinct product acquisition costs | −$90,000 |
| Distinct contractual adjustment not reflected above | −$4,000 |
| Distinct specified labor cost | −$7,000 |
| Remainder after these specified costs | $9,000 |
Reconcile actual full-year pharmacist/technician/support payroll, supervision, premises, equipment, software/billing, insurance and overhead. Map owner roles with the coverage guide and support each adjustment using the earnings bridge. Personal, vehicle, renovation and owner-pay labels alone do not establish removable costs.
Define inventory and actual operating rights
FDA outlines pharmacy trading-partner and product-tracing responsibilities.
(FDA: pharmacist DSCSA responsibilities overview)Have appropriate pharmacy/legal professionals assess actual applicability/current exceptions and supplier/tracing arrangements. Review controlled-substance and other particular activities separately where relevant. Reconcile counts, title, invoices/credits, supplier-owned items, expiry/condition, recalls and storage/transfer/return/disposal questions. Define eligible stock, valuation, inclusion versus additional price and disputes; a remaining ledger is separate from agreed value and permitted transfer.
Inspect actual equipment appropriately; review ownership/leases, liens, maintenance and investment. Have counsel, boards/agencies and payers assess proposed entity, pharmacists, services and location. Use the consent register for payer/PBM, wholesaler, software and premises rights. Historic seller payment does not establish buyer participation. Avoid adding stock/equipment already included in a comparison, price or closing adjustment.
Compare records, obligations and actual consideration
HHS describes conditions on health-data use/disclosure and safeguards.
(HHS: health-information privacy and security overview)Have privacy/pharmacy counsel assess permitted evidence, access/custody and migration. An NDA alone is insufficient grounds to upload identifiable prescription/patient files; future refill choice and collections are separate from historic counts.
Define receivables, claims/recoupment questions, supplier balances, deposits, prepaid services, refunds and uncompleted patient duties using the delivery guide. Compare cash, adjustments, conditional consideration, actual rights, required people and investment. Have appropriate counsel/accounting/valuation professionals assess actual arrangements and allocation. An educational scenario does not certify a pharmacy value or guarantee reimbursement.
Owner questions
What pharmacy multiple is supported here?
The table describes national 2021–2025 reported sold owner-earnings observations for primarily local retail pharmacies. Match actual earnings, activity and assets before using relevant comparisons.
Does more dispensing automatically mean more profit?
Reconcile actual receipts, product acquisition costs, contract adjustments, necessary labor and other annual costs.
Should medicine inventory be added to an earnings value?
First determine included assets and closing terms, then verify eligibility and agreed value without duplicate additions.
Sources and review scope
Source review completed . The sources below support the identified concepts or rules; they do not validate hypothetical amounts or a valuation of your business.
- BizBuySell: pharmacy sold benchmarks
National 2021–2025 reported sold pharmacy owner-earnings data, primarily local retail. Not specialty/compounding/platform EBITDA, per-script price or current appraisal.
- FDA: pharmacist DSCSA responsibilities overview
Overview of pharmacy trading-partner and product-tracing responsibilities. Actual applicability and current exceptions need review; not stock-transfer, dispensing or deal clearance.
- HHS: health-information privacy and security overview
September 2023 overview of conditional health-data use/disclosure and safeguards; not complete current transaction law.
Confirm tax, legal, accounting and lending applications with the relevant professionals. Historical market observations describe the stated period and reported sample.
This is educational material. Industry figures and program rules can change; check the original sources and your advisors before applying them to a transaction. Calculator scenarios are not appraisals, lending decisions, or offers.
Our content and calculator methodology →